⌘K

Login Start Free

Home/Filings/4/0000943819-25-000052

4//SEC Filing

Sandercock Brett 4

Accession 0000943819-25-000052

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 5:39 PM ET

Size

8.2 KB

Accession

0000943819-25-000052

Insider Transaction Report

Form 4

Period: 2025-09-02

Sandercock Brett

Chief Financial Officer

Transactions

Sale
ResMed Common Stock
2025-09-02$270.77/sh−3,000$812,310→ 87,745 total
Exercise/Conversion
ResMed Common Stock Options
2025-09-02−2,000→ 4,000 total
Exercise: $101.64From: 2019-11-11Exp: 2025-11-14→ ResMed Common Stock (2,000 underlying)
Exercise/Conversion
ResMed Common Stock
2025-09-02$101.64/sh+2,000$203,280→ 90,745 total

Footnotes (2)

[F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
[F2]Represents date options first become exercisable. Options vest 1/3 per year.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001346064

Filing Metadata

Form type: 4
Filed: Sep 2, 8:00 PM ET
Accepted: Sep 3, 5:39 PM ET
Size: 8.2 KB

View on SEC.gov